Lactoferrin

Subscribe to Selected New Research on Lactoferrin

1180 relevant articles (64 outcomes, 161 trials/studies) found for this Bio-Agent

Description: An iron-binding protein in plasma and secretions (milk, mucus, bile), secreted by leukocytes. It is an important component of GRANULOCYTES. It is bacteriostatic, working by depriving bacteria of iron essential for growth.

Also Known As:

Lactotransferrin

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins

talactoferrin alfa: 7

Boc-Lys(Boc)-Arg-Asp-Ser(tBu)-OtBu: 4

apolactoferrin: 2

KRDS peptide: 1

human hololactoferrin

human lactoferrin peptide 2

lactoferrin (318-323)

lactoferrin (536-540)

lactoferrin (673-679)

lactoferrin-DTPA-Eu conjugate

LFampin 265-284

Lfpep peptide

synthetic HLP1 protein

Carrier Proteins: 7795

Iron-Binding Proteins: 57

Lactoferrin: 1180

lactoferricin B: 27

talactoferrin alfa: 7

Boc-Lys(Boc)-Arg-Asp-Ser(tBu)-OtBu: 4

apolactoferrin: 2

KRDS peptide: 1

human hololactoferrin

human lactoferrin peptide 2

lactoferrin (318-323)

lactoferrin (536-540)

lactoferrin (673-679)

lactoferrin-DTPA-Eu conjugate

LFampin 265-284

Lfpep peptide

synthetic HLP1 protein

Dietary Proteins: 1248

talactoferrin alfa: 7

Boc-Lys(Boc)-Arg-Asp-Ser(tBu)-OtBu: 4

apolactoferrin: 2

KRDS peptide: 1

human hololactoferrin

human lactoferrin peptide 2

lactoferrin (318-323)

lactoferrin (536-540)

lactoferrin (673-679)

lactoferrin-DTPA-Eu conjugate

LFampin 265-284

Lfpep peptide

synthetic HLP1 protein

talactoferrin alfa: 7

Boc-Lys(Boc)-Arg-Asp-Ser(tBu)-OtBu: 4

apolactoferrin: 2

KRDS peptide: 1

human hololactoferrin

human lactoferrin peptide 2

lactoferrin (318-323)

lactoferrin (536-540)

lactoferrin (673-679)

lactoferrin-DTPA-Eu conjugate

LFampin 265-284

Lfpep peptide

synthetic HLP1 protein

Metalloproteins: 33

Iron-Binding Proteins: 57

Lactoferrin: 1180

lactoferricin B: 27

talactoferrin alfa: 7

Boc-Lys(Boc)-Arg-Asp-Ser(tBu)-OtBu: 4

apolactoferrin: 2

KRDS peptide: 1

human hololactoferrin

human lactoferrin peptide 2

lactoferrin (318-323)

lactoferrin (536-540)

lactoferrin (673-679)

lactoferrin-DTPA-Eu conjugate

LFampin 265-284

Lfpep peptide

synthetic HLP1 protein

Experts

1.	Yamauchi, Koji: 9 articles (04/2008 - 03/2002)
2.	Teraguchi, Susumu: 7 articles (09/2006 - 03/2002)
3.	Wakabayashi, Hiroyuki: 6 articles (06/2006 - 08/2003)
4.	Kaito, Masahiko: 5 articles (11/2007 - 03/2002)
5.	Adachi, Yukihiko: 5 articles (11/2007 - 03/2002)
6.	Kruzel, Marian L: 5 articles (01/2007 - 01/2003)
7.	Superti, Fabiana: 5 articles (11/2006 - 02/2002)
8.	Tanaka, Katsuaki: 5 articles (10/2006 - 04/2002)
9.	Tamura, Yoshitaka: 5 articles (08/2005 - 08/2003)
10.	Iwasa, Motoh: 4 articles (11/2007 - 03/2002)

Related Diseases

1.	Infection 08/01/2008 - "Lactoferrin is considered an important first line defense protein involved in protection against various microbial infections. " 01/01/2008 - "Application of bovine lactoferrin (LF), 10 mg i.v., 24 h before infection, was also very effective in reducing CFU numbers. " 01/01/2006 - "In conclusion, specific bacteriophage therapy combined with the administration of lactoferrin proved to be effective in the treatment of antibiotic-resistant external ear infection." 02/13/2008 - "In this study, we developed a transgenic mouse model for demonstrating the protective effects of recombinant lactoferrin (LF) against EV71 infection. " 12/01/1998 - "To investigate a potential new treatment for gastric Helicobacter pylori infection, we have examined the use of the natural antibiotic lactoferrin, found in bovine milk, for activity against Helicobacter species both in vitro and in vivo. " Order ALL the reference details at left...
2.	Inflammation 08/01/1998 - "Circulating lactoferrin is cleared in the liver, but little is known about the implication of lactoferrin in hepatic inflammation. " 06/30/2006 - "The fecal lactoferrin ELISA provides a non-invasive, quantitative assessment of intestinal inflammation, which should facilitate longitudinal studies of the development of and/or therapies reducing intestinal inflammation in individual mice and reduce the number of mice needed for such studies." 01/01/1998 - "This manuscript is intended to provide an overview of work related to lactoferrin's modulatory roles in inflammation, and to present observations from experimental studies on the preservation of intestinal structure and function by lactoferrin during intestinal inflammation. " 01/01/1994 - "The first series of studies addressed the putative role of lactoferrin in the pathogenesis of the hypoferremic, hyperferritinemic response to acute inflammation. " 01/01/1994 - "This manuscript is intended to provide an overview of work performed to date related to this controversy and to present results of a number of preliminary studies which shed further light on the role of lactoferrin in inflammation." Order ALL the reference details at left...
3.	Neoplasms (Cancer) 09/01/2003 - "Lactoferrin proved effective in reducing malignant tumor growth in a murine model. " 03/10/2003 - "Consistent downregulation of human lactoferrin gene, in the common eliminated region 1 on 3p21.3, following tumor growth in severe combined immunodeficient (SCID) mice." 01/01/2002 - "Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies." 03/01/2009 - "Lactoferrin and cancer disease prevention." 05/01/2008 - "These findings demonstrate that bovine lactoferrin has anti-tumor activity in canine mammary tumors and has the potential for use in tumor-bearing dogs." Order ALL the reference details at left...
4.	Mastitis 11/01/2006 - "The aim of the study was to investigate the concentrations in milk and protective effects of bovine and recombinant human lactoferrin in experimental Escherichia coli mastitis. " 08/01/2004 - "The efficacy of bovine lactoferrin in the treatment of cows with experimentally induced Escherichia coli mastitis." 01/01/2009 - "The data presented in this study emphasises the potential for lactoferrin to serve as a candidate gene to select for mastitis resistance with the aim of improving animal health." 11/01/2006 - "This is the first study describing an experimental mastitis model using transgenic cows expressing recombinant human lactoferrin (rhLf) in their milk. " 05/01/2004 - "Study on the polymorphism of bovine lactoferrin gene and its relationship with mastitis." Order ALL the reference details at left...
5.	Crohn Disease (Crohn's Disease) 11/01/2009 - "Finally, in patients with Crohn's disease who have undergone ileocolonic resection, those with higher lactoferrin fecal levels might be more prone to postsurgical recurrence." 04/01/2007 - "RESULTS: Lactoferrin levels were significantly higher in patients with ulcerative colitis (1880 +/- 565 microg/mL) (mean +/- SE) or Crohn disease (1701 +/- 382 microg/mL) than in healthy control individuals under 21 years of age (1.17 +/- 0.47 microg/mL, P < 0.001). " 06/01/2004 - "Fecal lactoferrin is a sensitive and specific biomarker representing intestinal inflammation and response to therapy in pediatric patients with Crohn's disease. " 08/01/1994 - "The fecal lactoferrin concentration of 38 patient with active ulcerative colitis was 307.4 +/- 233.9 micrograms/g feces, and that in 36 patients with active Crohn's disease was 191.7 +/- 231.1 micrograms/g feces. " 10/01/2007 - "Calprotectin and lactoferrin were significantly elevated in patients with Crohn's disease with CDAI>150 compared with those in remission. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Iron
2.	Peroxidase (Myeloperoxidase)
3.	Muramidase (Lysozyme)
4.	Antigens
5.	Leukocyte L1 Antigen Complex (Calgranulin)
6.	Carrier Proteins (Binding Protein)
7.	BCG Vaccine
8.	Lactoferrin
9.	Anti-Bacterial Agents (Antibiotics)
10.	Penicillins (Penicillin)

Related Therapies and Procedures

1.	Oral Administration
2.	Fluid Therapy (Oral Rehydration Therapy)
3.	Erythrocyte Transfusion
4.	Bone Marrow Transplantation (Transplantation, Bone Marrow)
5.	Chest Tubes (Chest Tube)

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 14726 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>